Here, we discovered that TAB182 promotes the stemness and tumorigenicity of ESCC cells by triggering the nucleus translocation of β-catenin to stimulate the β-catenin pathway, which leads to the activated transcription of JUN, MYC, ALDH1A1, CD44, and CD133. The gene discussed is CD44; the disease is esophageal squamous cell carcinoma.